$TPIV Hit $1.56 This Morning!
October 6th, 2009 at 6:58 am Posted by The Dean
$TPIV hit $1.56 for a potential profit of 48.6% this morning!
TapImmune Inc. (OTC: TPIV) is a biotechnology company that specializes in innovative therapies and vaccines for cancer and infectious diseases. $TPIV‘s leading product is the TAP vaccine which acts as a marker to identify and kills cancer cells.
The Dean thinks his students have a chance to TAP into some real profits because $TPIV‘s vaccine could kill cancer and Smallpox.
So far, $TPIV‘s product has been added to a smallpox vaccine and improved its potency by up to 1,000 times—and $TPIV isn’t a one hit wonder—it’s a KNOCKOUT that will make competition TAP out or BUY OUT!
The Dean thinks $TPIV is a winner because it’s part of the cancer and vaccine markets. The vaccine market raked in $10 billion in 2007 and is expected to increase by 238% to $23.8 billion within the next year.
Today could be another interesting day for $TPIV and he will keep the CollegeStock Community up-to-date with The Dean’s TAP on profits.
Students have until October 10th to become eligible for The Dean’s first ever Scholarship Fund contest. To be eligible, you MUST be an Honors Student. With The Dean giving away $5,000 to one top-performing Honors Students every quarter, $9.87/month to register for Honors Class is the ONLY way to get to the head of the class.
